FMP - Final Report WP2 on Proteomics and Metabolomics.pdf
WP2: Review of advances in toxicogenomics with relevance for the reduction of uncertainties in EMF related cancer risk assessment. Top-down approach: Overall assessment of the potential contribution of toxicogenomics (focused on proteomics and metabolomics) to close knowledge gaps in current EMF cancer risk assessment
Size 165.3 kB - File type application/pdf





